Casimiro Luca Gigliotti

Statistics

Publications

Citations

1.9K

H-Index

Active since

2010

Affiliations

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”(Current)

University of Turin

Centro de Investigaciones Biológicas Margarita Salas

Consejo Superior de Investigaciones Científicas

Tokyo Women's Medical University

Casimiro Luca Gigliotti is an author at Università degli Studi del Piemonte Orientale “Amedeo Avogadro” specializing in pharmacology, oncology, and nanomedicine.

ORCID

Publications per year

2010–2023

Publications

Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH

Salvatore Sutti, Aastha Jindal, Irene Locatelli et al. · Hepatology · 2013 · 270 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis

Giuseppe Cappellano, Abiy Demeke Woldetsadik, Elisabetta Orilieri et al. · Vaccine · 2014 · 152 citations · Full text

Pharmacy, Immunology, Autoimmunity +11

GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses

Martina Daga, Chiara Ullio, Monica Argenziano et al. · Free Radical Biology and Medicine · 2016 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +17

Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models

Monica Argenziano, Casimiro Luca Gigliotti, Nausicaa Clemente et al. · Cancers · 2020 · 85 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies

Nausicaa Clemente, Benedetta Ferrara, Casimiro Luca Gigliotti et al. · International Journal of Molecular Sciences · 2018 · 84 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–5 of 39